Search research articles
Contact Us
Filters
Showing results (1-10 of 25) with videos related to
Page
of 3
Sort By:
Expert Opinion on Therapeutic Patents
|
March 3, 2010
Non-erythropoietic tissue-protective peptides derived from erythropoietin: WO2009094172
Francis Dumont, Pierre Bischoff
Current Cancer Drug Targets
|
July 27, 2012
Disrupting the mTOR signaling network as a potential strategy for the enhancement of cancer radiotherapy
Francis J Dumont, Pierre Bischoff
Expert Opinion on Therapeutic Patents
|
May 22, 2009
Radiosensitising agents for the radiotherapy of cancer: novel molecularly targeted approaches
Francis Dumont, Anais Altmeyer, Pierre Bischoff
Expert Opinion on Therapeutic Patents
|
May 16, 2009
Radiosensitising agents for the radiotherapy of cancer: advances in traditional and hypoxia targeted radiosensitisers
Pierre Bischoff, Anais Altmeyer, Francis Dumont
Expert Opinion on Therapeutic Patents
|
August 7, 2012
Novel pharmacological modulators of autophagy and therapeutic prospects
Pierre Bischoff, Elodie Josset, Francis J Dumont
Expert Opinion on Therapeutic Patents
|
December 22, 2009
Radiation countermeasure agents: an update
Francis Dumont, Antoine Le Roux, Pierre Bischoff
Anticancer Research
|
May 7, 2013
The mTOR inhibitor RAD001 potentiates autophagic cell death induced by temozolomide in a glioblastoma cell line
Elodie Josset, Hélène Burckel, Georges Noël, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
September 26, 2024
Role of autophagy in modulating tumor cell radiosensitivity: Exploring pharmacological interventions for glioblastoma multiforme treatment
Pierre Bischoff, Jolie Bou-Gharios, Georges Noël, et al.
Current Medicinal Chemistry. Anti-Cancer Agents
|
May 29, 2003
Signal transduction pathways of taxanes-induced apoptosis
Valérie Ganansia-Leymarie, Pierre Bischoff, Jean-Pierre Bergerat, et al.
Bioorganic & Medicinal Chemistry
|
June 10, 2004
Synthesis and photocytotoxic activity of new alpha-methylene-gamma-butyrolactone-psoralen heterodimers
Sandrine Ropp, Julia Guy, Valérie Berl, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 25) with videos related to
Sort By:
Page
of 3
Expert Opinion on Therapeutic Patents
|
March 3, 2010
Non-erythropoietic tissue-protective peptides derived from erythropoietin: WO2009094172
Francis Dumont, Pierre Bischoff
Current Cancer Drug Targets
|
July 27, 2012
Disrupting the mTOR signaling network as a potential strategy for the enhancement of cancer radiotherapy
Francis J Dumont, Pierre Bischoff
Expert Opinion on Therapeutic Patents
|
May 22, 2009
Radiosensitising agents for the radiotherapy of cancer: novel molecularly targeted approaches
Francis Dumont, Anais Altmeyer, Pierre Bischoff
Expert Opinion on Therapeutic Patents
|
May 16, 2009
Radiosensitising agents for the radiotherapy of cancer: advances in traditional and hypoxia targeted radiosensitisers
Pierre Bischoff, Anais Altmeyer, Francis Dumont
Expert Opinion on Therapeutic Patents
|
August 7, 2012
Novel pharmacological modulators of autophagy and therapeutic prospects
Pierre Bischoff, Elodie Josset, Francis J Dumont
Expert Opinion on Therapeutic Patents
|
December 22, 2009
Radiation countermeasure agents: an update
Francis Dumont, Antoine Le Roux, Pierre Bischoff
Anticancer Research
|
May 7, 2013
The mTOR inhibitor RAD001 potentiates autophagic cell death induced by temozolomide in a glioblastoma cell line
Elodie Josset, Hélène Burckel, Georges Noël, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
September 26, 2024
Role of autophagy in modulating tumor cell radiosensitivity: Exploring pharmacological interventions for glioblastoma multiforme treatment
Pierre Bischoff, Jolie Bou-Gharios, Georges Noël, et al.
Current Medicinal Chemistry. Anti-Cancer Agents
|
May 29, 2003
Signal transduction pathways of taxanes-induced apoptosis
Valérie Ganansia-Leymarie, Pierre Bischoff, Jean-Pierre Bergerat, et al.
Bioorganic & Medicinal Chemistry
|
June 10, 2004
Synthesis and photocytotoxic activity of new alpha-methylene-gamma-butyrolactone-psoralen heterodimers
Sandrine Ropp, Julia Guy, Valérie Berl, et al.
Page
of 3